J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 7,490.00
+290.00 (4.03%)
At close: Jun 29, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 43.8 billion as of June 29, 2026. Its market cap has decreased by -29.67% in one year.
Market Cap
43.80B
Enterprise Value
35.53B
Revenue
36.82B
Ranking
n/a
PE Ratio
10.84
Stock Price
7,490.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 43.80B, a decrease of -69.78%. That is a compound annual growth rate of -41.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 43.80B | -12.91% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
| Mar 25, 2024 | 144.93B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 56.24B |
| EyeGene | 55.33B |
| TegoScience | 52.12B |
| Progen | 50.12B |
| Psomagen | 46.36B |
| Parataxis Korea | 44.13B |
| Aptamer Sciences | 44.01B |
| HLB Pep | 40.69B |